SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin.

Almanaa TN, Al-Kuraishy HM, Al-Gareeb AI, Abdelnaby MA, Alexiou A, Papadakis M, Abo-ElFetoh IE, Batiha GE.

DOI: 10.1007/s10787-025-02082-5
Published: 2025-12-18
Container: Inflammopharmacology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10787-025-02082-5,
  title = {SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin.},
  author = {Almanaa TN and  Al-Kuraishy HM and  Al-Gareeb AI and  Abdelnaby MA and  Alexiou A and  Papadakis M and  Abo-ElFetoh IE and  Batiha GE.},
  year = {2026},
  journal = {Inflammopharmacology},
  doi = {10.1007/s10787-025-02082-5},
  url = {https://doi.org/10.1007/s10787-025-02082-5}
}

RIS

TY  - JOUR
TI  - SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin.
AU  - Almanaa TN
AU  -  Al-Kuraishy HM
AU  -  Al-Gareeb AI
AU  -  Abdelnaby MA
AU  -  Alexiou A
AU  -  Papadakis M
AU  -  Abo-ElFetoh IE
AU  -  Batiha GE.
PY  - 2026
JO  - Inflammopharmacology
DO  - 10.1007/s10787-025-02082-5
UR  - https://doi.org/10.1007/s10787-025-02082-5
ER  -

APA

TN, A., HM, A., AI, A., MA, A., A, A., M, P., IE, A., & GE., B. (2026). SARS-CoV-2 infection and gut-lung axis: the potential role of rifaximin.. Inflammopharmacology. https://doi.org/10.1007/s10787-025-02082-5

Source records

europe-pmc · retrieved 2026-09-26T22:38:14.142Z